...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.
【24h】

Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.

机译:肾移植术后复发的IgA肾病中仅扁桃体切除术可降低蛋白尿作用。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Few studies have been conducted to determine the efficacy of tonsillectomy in suppressing IgA nephropathy recurring after the kidney transplantation. MATERIALS AND METHODS: Of the 405 kidney recipients who received allograft transplants at our institution between 1998 and 2005, 63 (63 of 405, 16%) were diagnosed as having recurrence of IgA nephropathy in the kidney graft. Among the 63 patients, our subjects in this study were 28 patients who were confirmed to have recurrence of IgA nephropathy by histopathological examination, and who had persistent urinary protein excretion levels of more than 300 mg/day despite medical treatments. Sixteen patients (group 1) underwent tonsillectomy alone, whereas the remaining 12 patients (group 2) did not receive tonsillectomy. The degree of proteinuria, kidney graft function, and blood pressure were analyzed retrospectively in the two patient groups. RESULTS: The urinary protein excretion decreased dramatically after the tonsillectomy in all of the 16 patients of group 1 (880+/-630 mg/day to 280+/-220 mg/day, P<0.01) but none of group 2. The reduction in urinary protein excretion after tonsillectomy was especially marked in the patients with mild mesangial changes, such as minor glomerular abnormalities, when compared with that in patients with severe mesangial changes, such as diffuse proliferative glomerular abnormalities (mean percent decrease in the urinary protein excretion rate at 12 months after tonsillectomy; 31% minor glomerular abnormalities vs. 62% diffuse proliferative glomerular abnormalities, P<0.01). CONCLUSION: These results suggest that in patients receiving oral immunosuppressive therapy for recurrence of IgA nephropathy after the kidney transplantation, reduction of the urinary protein excretion can be expected with tonsillectomy alone, without accompanying pulsed steroid therapy.
机译:背景:很少有研究确定扁桃体切除术在抑制肾移植后复发的IgA肾病中的功效。材料与方法:在1998年至2005年间我们机构接受同种异体移植的405位肾脏接受者中,有63位(405位中的63位,占16%)被诊断为肾脏移植物中IgA肾病复发。在这63名患者中,本研究的受试者为28名经组织病理学检查证实已复发IgA肾病的患者,尽管进行了药物治疗,但其尿蛋白排泄水平持续超过300 mg / day。 16名患者(第1组)仅接受扁桃体切除术,而其余12名患者(第2组)未进行扁桃体切除术。回顾性分析两组患者的蛋白尿程度,肾移植功能和血压。结果:在第1组的所有16例患者中,扁桃体切除后尿蛋白排泄显着降低(880 +/- 630 mg / day至280 +/- 220 mg / day,P <0.01),但第2组均无。与轻度系膜改变(例如轻度肾小球异常)的患者相比,扁桃体切除术后尿蛋白排泄的减少特别明显,而轻度肾小球系膜改变(例如弥漫性增生性肾小球异常)的患者则明显减少(尿蛋白排泄的平均百分比降低)扁桃体切除术后12个月的比率;轻度肾小球异常为31%,弥漫性增生性肾小球异常为62%,P <0.01)。结论:这些结果表明,在接受肾脏移植后IgA肾病复发的口服免疫抑制治疗的患者中,仅进行扁桃体切除术就可以减少尿蛋白排泄,而无需伴随脉冲类固醇治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号